A Machine to Make a Future (eBook)

Biotech Chronicles

Paul Rabinow, Talia Dan-Cohen (Autoren)

eBook Download: PDF | EPUB

2013
224 Seiten
Princeton University Press (Verlag)
978-1-4008-4966-6 (ISBN)

Infos

Paul Rabinow is Professor of Anthropology at the University of California, Berkeley. His many books include French DNA, Making PCR, and Anthropos Today (Princeton). Talia Dan-Cohen received a B.A. in anthropology from the University of California, Berkeley.

---

A Machine to Make a Future represents a remarkably original look at the present and possible future of biotechnology research in the wake of the mapping of the human genome. The central tenet of Celera Diagnostics--the California biotech company whose formative work during 2003 is the focus of the book--is that the emergent knowledge about the genome, with its profound implications for human health, can now be turned into a powerful diagnostic apparatus--one that will yield breakthrough diagnostic and therapeutic products (and, potentially, profit). Celera's efforts--assuming they succeed--may fundamentally reshape the fabric of how health and health care are understood, practiced, and managed. Presenting a series of interviews with all of the key players in Celera Diagnostics, Paul Rabinow and Talia Dan-Cohen open a fascinating window on the complexity of corporate scientific innovation. This marks a radical departure from other books on the biotech industry by chronicling the vicissitudes of a project during a finite time period, in the words of the actors themselves. Ultimately, the authors conclude, Celera Diagnostics is engaged in a future characterized not by geniuses and their celebrated discoveries but by a largely anonymous and widely distributed profusion of data and results--a "e;machine to make a future."e; In their new afterword, Rabinow and Dan-Cohen revisit Celera Diagnostics as its mighty machine grinds along, wondering, along with the scientists, "e;what constitutes success and what constitutes failure?"e; The pathos of the situation turns on how one poses the question as much as how one answers it.

Produkt-Details

• Erscheint lt. Verlag: 31.10.2013
• Zusatzinfo: 8 halftones.
• Verlagsort: Princeton
• Sprache: englisch
• Themenwelt: Geisteswissenschaften ► Philosophie ► Ethik
• Themenwelt: Studium ► 2. Studienabschnitt (Klinik) ► Humangenetik
• Themenwelt: Naturwissenschaften ► Biologie ► Genetik / Molekularbiologie
• Themenwelt: Recht / Steuern ► Öffentliches Recht
• Themenwelt: Sozialwissenschaften ► Ethnologie
• Themenwelt: Sozialwissenschaften ► Pädagogik
• Themenwelt: Sozialwissenschaften ► Politik / Verwaltung
• Themenwelt: Sozialwissenschaften ► Soziologie
• Themenwelt: Technik ► Umwelttechnik / Biotechnologie
• Schlagworte: Affymetrix • Allele • Alzheimer's disease • Applera • Applied Biosystems • assay • Barcode • Bioinformatics • Biology • Biotechnology • Breast Cancer • Bristol-Myers Squibb • Business Ethics • Business Model • Business Plan • Calculation • Candidate Gene • Cardiovascular Disease • Career • Cetus Corporation • circulatory system • clinical trial • Clinician • Cohort Study • Commercialization • Competition • conference call • Consultant • Craig Venter • Cystic fibrosis • Deliberation • Diagnosis • Disease • drug development • drug discovery • Emergence • Enzyme • Estrogen • Estrogen Receptor • failure rate • Filing (legal) • Finding • Funding • Genetic Discrimination • Genetic marker • Genetic Testing • genome project • genomics • Genotype • genotyping • Good Manufacturing Practice • Health Care • Health Insurance Portability and Accountability Act • Hoffmann-La Roche • human genome • human genome project • Indication (medicine) • Infrastructure • institutional review board • Intellectual Property • it works • Johnson • Johnson &amp • Johnson & Johnson • LabCorp • Manufacturing • Marketing • medical genetics • Medical literature • Molecular Biology • narrative • Patent • patent attorney • Pathology • PerkinElmer • pharmaceutical drug • Pharmaceutical Industry • Physician • Point mutation • Portion • principal investigator • Prostate Cancer • Protein • Publication • Quantity • reagent • Requirement • Research and Development • result • Rheumatoid Arthritis • Robotics • Sample Size • scientific enterprise • Scientific journal • Scientist • sequencing • Sequenom • statistical power • statistical significance • Technology • thrombosis • year
• ISBN-10: 1-4008-4966-7 / 1400849667
• ISBN-13: 978-1-4008-4966-6 / 9781400849666